NVOON (Novo Nordisk (Ondo Tokenized Stock)) will be listed on LBank at 08:00 on June 9, 2026 (UTC). The details are as follows:
-
About NVOON (Novo Nordisk (Ondo Tokenized Stock))
Novo Nordisk (NYSE: NVO) is a Danish pharmaceutical giant and the global leader in diabetes and obesity care, with GLP-1 drug Ozempic (semaglutide) and weight-loss drug Wegovy as its core products.
The transaction fee of NVOON/USDT is Taker (0.2%), Maker (0.2%).
Based on market conditions, LBank may adjust the trading parameters of the spot market from time to time, which may include the minimum order quantity, price precision, or other relevant parameters without further announcement.